Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 425-320-1 | CAS number: 690-39-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- sub-chronic toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP compliance , but no test guideline stated.
Data source
Reference
- Reference Type:
- other: inquiry result from ECHA
- Title:
- Unnamed
- Year:
- 2 013
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: No test guideline stated in the report.
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- -
- EC Number:
- 425-320-1
- EC Name:
- -
- Cas Number:
- 690-39-1
- Molecular formula:
- C3H2F6
- IUPAC Name:
- 1,1,1,3,3,3-hexafluoropropane
Constituent 1
Test animals
- Species:
- other: Rat, Crl : CD BR
Administration / exposure
- Route of administration:
- inhalation
- Vehicle:
- other: Filtered, conditioned dilution air.
- Details on inhalation exposure:
- Method of exposure:
inhalation, whole body exposure
Mass median aerodynamic diameter:
not applicable - Duration of treatment / exposure:
- Test duration: 90 days
- Frequency of treatment:
- Duration of exposure per day: 6 hours
Dosing regime: 5 days/week
- No. of animals per sex per dose:
- Male: 5 animals at 0 mg/l
Male: 5 animals at 5000 mg/l
Male: 5 animals at 20000 mg/l
Male: 5 animals at 50000 mg/l
Female: 5 animals at 0 mg/l
Female: 5 animals at 5000 mg/l
Female: 5 animals at 20000 mg/l
Female: 5 animals at 50000 mg/l
Results and discussion
Results of examinations
- Details on results:
- Clinical observations:
The substance had no effect on body weights, no abnormal clinical observations were seen in rats either prior to or following exposures.
The one notable compound-related effect was a diminished response to an alerting stimulus during exposure in the 50000 ppm male and female rats during the first week of the study. A diminished alerting response was noted in some rats primarily during the last two hours of the exposure. The number of rats affected generally decreased with sucessive exposures such that by study day 18, all rats from this group had a normal alerting response. All rats exhibited normal alerting response during the evaluation period immediately after exposure.
Laboratory findings:
No effect on the food consumption or food efficiency was observed.
Effects in organs:
No compound-related effects were detected during the ophthalmological and clinical pathology evaluations. No organ weight differences were seen during necropsy and no histopathologic changes were observed upon microscopic evaluation of tissues. No biologically significant alterations in hepatic peroxisomal á-oxidation activity were seen in any group.
Effect levels
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 20 000 mg/L air
- Basis for effect level:
- other: exposure duration: 6 hours/day NOAEL=2000 ppm (124000 mg/m3)
- Dose descriptor:
- NOEC
- Effect level:
- 20 000 mg/L air
- Basis for effect level:
- other: exposure duration: 6 hours/day NOAEL=2000 ppm (124000 mg/m3)
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Classified as: Not classified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.